Skip to main content

Advertisement

Table 4 Multivariable analysis of factors associated with in-hospital mortality among type 2 diabetes (T2DM) patients according to the type of surgical aortic valve replacement (SAVR)

From: Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical aortic valve replacement in Spain (2001–2015)

  Mechanical SAVR OR (95% CI) Bioprosthetic SAVR OR (95% CI) Both types of SAVR OR (95% CI)
Years
 2001–2003 1 1 1
 2004–2006 0.75 (0.58–0.96) 1.14 (0.76–1.70) 0.85 (0.69–1.05)
 2007–2009 0.78 (0.61–1.00) 0.90 (0.61–1.33) 0.80 (0.65–0.98)
 2010–2012 0.51 (0.39–0.67) 0.60 (0.40–0.89) 0.52 (0.42–0.65)
 2013–2015 0.39 (0.30–0.52) 0.47 (0.32–0.70) 0.41 (0.33–0.50)
Sex
 Female 1.47 (1.24–1.74) 1.29 (1.06–1.57) 1.39 (1.23–1.59)
Age groups (years)
 40–64 1 1 1
 65–74 1.56 (1.24–1.97) 0.96 (0.58–1.59) 1.49 (1.22–1.84)
 75–84 2.21 (1.74–2.82) 1.23 (0.75–2.02) 2.01 (1.63–2.49)
 ≥ 85 2.83 (1.44–5.56) 1.83 (0.89–3.77) 2.82 (1.79–4.43)
CCI
 0 1 1 1
 1 2.62 (2.13–3.22) 2.22 (1.74–2.82) 2.44 (2.09–2.85)
 2+ 4.50 (3.61–5.61) 4.45 (3.47–5.70) 4.50 (3.82–5.31)
CABG 1.27 (1.06–1.52) 1.30 (1.06–1.59) 1.28 (1.12–1.47)
SAVR type
 Mechanical NA NA 1.66 (1.45–1.90)
  1. Only those variables with a significant association are shown
  2. CABG, coronary artery bypass surgery; CCI, Charlson Comorbidity Index; OR, odds ratio obtained using logistic regression models; 95% CI: 95% confidence intervals; NA, not applicable